CEPHAGENIX

Cephagenix was founded in February 2020, with the aim of identifying and developing new effective migraine treatments... Cephagenix aims to develop first-in-class KATP channel inhibitors as an efficacious and safe treatment of migraine.

Primary location: Paris France